← Back to All Filings

Linde PLC Director Awarded Equity Grant of ~493 Shares

Low SignificanceMarch 10, 2026 at 6:02:33 PM EDT

LINDE PLC

$LIN4CIK: 0001707925

Subscribe to track LIN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Linde PLC Director Awarded Equity Grant of ~493 Shares

Company: LINDE PLC (LIN) Form: 4 | Filed: 2026-03-10 Significance: Low

Insider: Reynolds Paula Rosput Title: Director | Relationship: Director

Transaction: • Type: Grant (Award) • Shares: 492.808 • Price: $0.00 • Value: $0 (Grant) • Owned After: 715.922 (Direct Ordinary Shares)

Key Insight: Routine director compensation via Restricted Stock Units and Deferred Stock Units. Transaction represents negligible dilution (<0.0001% of float).

Market Context: Transaction is standard governance compensation and does not signal open market sentiment.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: LINDE PLC (LIN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Director Paula Rosput Reynolds received a routine equity grant of Restricted Stock Units and Deferred Stock Units.
  • Market Impact: Neutral; standard compensation activity with no material dilution.

Company Information

FieldValue
CompanyLINDE PLC
Ticker SymbolLIN
CIK0001707925
IndustryIndustrial Inorganic Chemicals

Insider Information

FieldValue
NameReynolds Paula Rosput
CIK0001179998
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-09
Transaction CodeA (Grant/Award)
Security TypeRestricted Stock Units & Deferred Stock Units
Shares Involved492.808
Price Per Share$0.00
Total Value$0.00 (Compensation Grant)
Shares Owned After715.922 (Ordinary Shares)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0 (Grant)
% of Market Cap0.00%
Shares Transacted492.808
% of Shares Outstanding~0.0001%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $224.63 billion, this transaction is financially immaterial.
  • Dilution Impact: The grant represents approximately 0.0001% of the 463.39 million shares outstanding, resulting in zero effective dilution for shareholders.
  • Transaction Significance: This is a routine governance event (Code A) representing director compensation rather than an open market purchase or sale.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a scheduled compensation grant with no economic signal regarding the director's view of the stock's future performance.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Details: The reporting person acquired 473 RSUs and 19.808 Deferred Stock Units. The RSUs vest in one year (March 2027).
  • Deferral: Payout of the vested RSU award has been deferred until the reporting person's termination of service on the Board.
Topics:#LIN#LindePLC#SECFiling#Form4#InsiderTrading#StockGrant#CorporateGovernance#FinancialEducation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.